References
Bennette, C. S., C. J. Gallego, W. Burke, G. P. Jarvik, and D. L. Veenstra. 2015. The cost-effectiveness of returning incidental findings from next-generation genomic sequencing. Genetics in Medicine 17(7):587–595.
Canto, J. G., C. I. Kiefe, W. J. Rogers, E. D. Peterson, P. D. Frederick, W. J. French, C. M. Gibson, C. V. Pollack, Jr., J. P. Ornato, R. J. Zalenski, J. Penney, A. J. Tiefenbrunn, P. Greenland, and NRMI Investigators. 2011. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA 306(19):2120–2127.
Carey, D. J., S. N. Fetterolf, F. D. Davis, W. A. Faucett, H. L. Kirchner, U. Mirshahi, M. F. Murray, D. T. Smelser, G. S. Gerhard, and D. H. Ledbetter. 2016. The Geisinger MyCode community health initiative: An electronic health record-linked biobank for precision medicine research. Genetics in Medicine 18(9):906–913.
Cavallari, L. H., and M. A. Perera. 2012. The future of warfarin pharmacogenetics in underrepresented minority groups. Future Cardiology 8(4):563–576.
Chambers, D. A., W. G. Feero, and M. J. Khoury. 2016. Convergence of implementation science, precision medicine, and the learning health care system: A new model for biomedical research. JAMA 315(18):1941–1942.
Damschroder, L. J., D. C. Aron, R. E. Keith, S. R. Kirsh, J. A. Alexander, and J. C. Lowery. 2009. Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science. Implementation Science 4:50.
Dewey, F. E., V. Gusarova, C. O’Dushlaine, O. Gottesman, J. Trejos, C. Hunt, C. V. Van Hout, L. Habegger, D. Buckler, K. M. Lai, J. B. Leader, M. F. Murray, M. D. Ritchie, H. L. Kirchner, D. H. Ledbetter, J. Penn, A. Lopez, I. B. Borecki, J. D. Overton, J. G. Reid, D. J. Carey, A. J. Murphy, G. D. Yancopoulos, A. Baras, J. Gromada, and A. R. Shuldiner. 2016. Inactivating variants in ANGPTL4 and risk of coronary artery disease. New England Journal of Medicine 374(12):1123–1133.
Dotson, W. D., M. P. Douglas, K. Kolor, A. C. Stewart, M. S. Bowen, M. Gwinn, A. Wulf, H. M. Anders, C. Q. Chang, M. Clyne, T. K. Lam, S. D. Schully, M. Marrone, W. G. Feero, and M. J. Khoury. 2014. Prioritizing genomic applications for action by level of evidence: A horizon-scanning method. Clinical Pharmacology & Therapeutics 95(4): 394–402.
Foster, M. W., J. J. Mulvihill, and R. R. Sharp. 2009. Evaluating the utility of personal genomic information. Genetics in Medicine 11(8):570–574.
Gage, B. F., A. R. Bass, H. Lin, S. C. Woller, S. M. Stevens, N. Al-Hammadi, J. Li, T. Rodriguez, Jr., J. P. Miller, G. A. McMillin, R. C. Pendleton, A. K. Jaffer, C. R. King, B. DeVore Whipple, R. Porche-Sorbet, L. Napoli, K. Merritt, A. M. Thompson, G. Hyun, J. L. Anderson, W. Hollomon, R. L. Barrack, R. M. Nunley, G. Moskowitz, V. DavilaRoman, and C. S. Eby. 2017. Effect of genotype-guided warfarin dosing on clinical events and anticoagulation control among patients undergoing hip or knee arthroplasty. The GIFT randomized control trial. JAMA 318(12):1115–1124.
Genovese, G., D. J. Friedman, M. D. Ross, L. Lecordier, P. Uzureau, B. I. Freedman, D. W. Bowden, C. D. Langefeld, T. K. Oleksyk, A. L. Uscinski Knob, A. J. Bernhardy, P. J. Hicks, G. W. Nelson, B. Vanhollebeke, C. A. Winkler, J. B. Kopp, E. Pays, and M. R. Pollak. 2010. Association of trypanolytic APOL1 variants with kidney disease in African Americans. Science 329(5993):841–845.
Graves, J. A., S. Garbett, Z. Zhou, and J. Peterson. 2017. The value of pharmacogenomic information. NBER Working Paper 24134. http://www.nber.org/papers/w24134.pdf (accessed March 9, 2018).
Green, L. A., G. E. Fryer, Jr., B. P. Yawn, D. Lanier, and S. M. Dovey. 2001. The ecology of medical care revisited. New England Journal of Medicine 344(26):2021–2025.
Green, R. C., J. S. Berg, W. W. Grody, S. S. Kalia, B. R. Korf, C. L. Martin, and L. G. Biesecker. 2013. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine 15(7):565–574.
Griffiths, A. J. F., J. H. Miller, D. T. Suzuki, R. C. Lewontin, and W. M. Gelbart. 2000. Penetrance and expressivity. An introduction to genetic analysis, 7th edition. New York: W.H. Freeman. https://www.ncbi.nlm.nih.gov/books/NBK22090 (accessed March 9, 2018).
Grosse, S. D., L. Kalman, and M. J. Khoury. 2010. Evaluation of the validity and utility of genetic testing for rare diseases. Advances in Experimental Medicine and Biology 686:115–131.
Horowitz, C. R., K. Ferryman, R. Negron, T. Sabin, M. Rodriguez, R. F. Zinberg, E. Böttinger, and M. Robinson. 2017. Race, genomics and chronic disease: What patients with African ancestry have to say. Journal of Health Care for the Poor and Underserved 28(1): 248–260.
IOM (Institute of Medicine). 2013. Observational studies in a learning health system: Workshop summary. Washington, DC: The National Academies Press.
IOM. 2015. Genomics-enabled learning health care systems: Gathering and using genomic information to improve patient care and research: Workshop summary. Washington, DC: The National Academies Press.
Kalia, S. S., K. Adelman, S. J. Bale, W. K. Chung, C. Eng, J. P. Evans, G. E. Herman, S. B. Hufnagel, T. E. Klein, B. R. Korf, K. D. McKelvey, K. E. Ormond, C. S. Richards, C. N. Vlangos, M. Watson, C. L. Martin, and D. T. Miller. 2017. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): A policy statement of the American College of Medical Genetics and Genomics. Genetics in Medicine 19(2):249–255.
Kaplan, B., C. Caddle-Steele, G. Chisholm, W. A. Esmond, K. Ferryman, M. Gertner, C. Goytia, D. Hauser, L. D. Richardson, M. Robinson, and C. R. Horowitz. 2017. A culture of understanding: Reflections and suggestions from a genomics research community board. Progress in Community Health Partnerships 11(2):161–165.
Khera, A. V., H. H. Won, G. M. Peloso, K. S. Lawson, T. M. Bartz, X. Deng, E. M. van Leeuwen, P. Natarajan, C. A. Emdin, A. G. Bick, A. C. Morrison, J. A. Brody, N. Gupta, A. Nomura, T. Kessler, S. Duga, J. C. Bis, C. M. van Duijn, L. A. Cupples, B. Psaty, D. J. Rader, J. Danesh, H. Schunkert, R. McPherson, M. Farrall, H. Watkins, E. Lander, J. G. Wilson, A. Correa, E. Boerwinkle, P. A. Merlini, D. Ardissino, D. Saleheen, S. Gabriel, and S. Kathiresan. 2016. Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia. Journal of the American College of Cardiology 67(22):2578–2589.
Kho, A. N., J. P. Cashy, K. L. Jackson, A. R. Pah, S. Goel, J. Boehnke, J. E. Humphries, S. D. Kominers, B. N. Hota, S. A. Sims, B. A. Malin, D. D. French, T. L. Walunas, D. O. Meltzer, E. O. Kaleba, R. C. Jones, and W. L. Galanter. 2015. Design and implementation of a privacy protecting electronic health record linkage tool in Chicago. Journal of the American Medical Informatics Association 22(5):1072–1080.
Kimmel, S. E., B. French, S. E. Kasner, J. A. Johnson, J. L. Anderson, B. F. Gage, Y. D. Rosenberg, C. S. Eby, R. A. Madigan, R. B. McBane, S. Z. Abdel-Rahman, S. M. Stevens, S. Yale, E. R. Mohler 3rd, M. C. Fang, V. Shah, R. B. Horenstein, N. A. Limdi, J. A. Muldowney 3rd, J. Gujral, P. Delafontaine, R. J. Desnick, T. L. Ortel, H. H. Billett, R. C. Pendleton, N. L. Geller, J. L. Halperin, S. Z. Goldhaber, M. D. Caldwell, R. M. Califf, and J. H. Ellenberg; for the COAG Investigators. 2013. A pharmacogenetic versus a clinical algorithm for warfarin dosing. New England Journal of Medicine 369(24):2283–2293.
Knight, S. J., A. F. Mohamed, D. A. Marshall, U. Ladabaum, K. A. Phillips, and J. M. Walsh. 2015. Value of genetic testing for hereditary colorectal cancer in a probability-based U.S. online sample. Medical Decision Making 35(6):734–744.
Kraft, S. A., J. L. Schneider, M. C. Leo, T. L. Kauffman, J. V. Davis, K. M. Porter, C. K. McMullen, B. S. Wilfond, and K. A. B. Goddard. 2018. Patient actions and reactions after receiving negative results from expanded carrier screening. Clinical Genetics. January 2. doi: 10.1111/cge.13206. [Epub ahead of print]. https://www.ncbi.nlm.nih.gov/pubmed/29293279 (accessed March 9, 2018).
Lancsar, E., and J. Louviere. 2008. Conducting discrete choice experiments to inform healthcare decision making. Pharmacoeconomics 26:661–677.
Lu, C. Y., M. S. Williams, G. S. Ginsburg, S. Toh, J. S. Brown, and M. J. Khoury. 2017. A proposed approach to accelerate evidence generation for genomics-based technologies in the context of a learning health system. Genetics in Medicine August 10. doi: 10.1038/gim.2017.122. [Epub ahead of print]. https://www.ncbi.nlm.nih.gov/pubmed/28796238 (accessed March 9, 2018).
Marshall, D. A., J. M. Gonzalez, K. V. MacDonald, and F. R. Johnson. 2017. Estimating preferences for complex health technologies: Lessons learned and implications for personalized medicine. Value in Health 20(1):32–39.
McFadden, D. 1974. Conditional logit analysis of qualitative choice behavior. In Frontiers in econometrics, edited by P. Zarembka. New York: Academic Press. Pp. 105–142.
NASEM (National Academies of Sciences, Engineering, and Medicine). 2016. Applying an implementation science approach to genomic medicine: Workshop summary. Washington, DC: The National Academies Press.
Neumann P., G. D. Sanders, L. B. Russell, J. E. Siegel, and T. G. Ganiats. 2017. Cost-effectiveness in health and medicine: 2nd edition. New York: Oxford University Press.
NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases). 2016. Kidney disease statistics for the United States. https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease (accessed January 24, 2018).
NIMH (National Institute of Mental Health). 2017. What is prevalence?https://www.nimh.nih.gov/health/statistics/prevalence/index.shtml (accessed January 22, 2018).
Orlando, L. A., N. R. Sperber, C. Voils, M. Nichols, R. A. Myers, R. R. Wu, T. Rakhra-Burris, K. D. Levy, M. Levy, T. I. Pollin, Y. Guan, C. R. Horowitz, M. Ramos, S. E. Kimmel, C. W. McDonough, E. B. Madden, and L. J. Damschroder. 2017. Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: The IGNITE Network’s Common Measures Working Group. Genetics in Medicine September 14. [Epub ahead of print]. https://www.ncbi.nlm.nih.gov/pubmed/28914267 (accessed March 9, 2018).
Peterson, J., J. Field, K. Unertl, J. Schildcrout, D. Johnson, Y. Shi, I. Danciu, J. Cleator, J. Pulley, J. McPherson, J. Denny, M. Laposata, D. Roden, and K. Johnson. 2016. Physician response to implementation of genotype-tailored antiplatelet therapy. Clinical Pharmacology & Therapeutics 100:67–74.
Phillips, K. A., P. A. Deverka, H. C. Sox, M. J. Khoury, L. G. Sandy, G. S. Ginsburg, S. R. Tunis, L. A. Orlando, and M. P. Douglas. 2017. Making genomic medicine evidence-based and patient-centered: A structured review and landscape analysis of comparative effectiveness research. Genetics in Medicine 19(10):1081–1091.
Pirmohamed, M., G. Burnside, N. Eriksson, A. L. Jorgensen, C. H. Toh, T. Nicholson, P. Kesteven, C. Christersson, B. Wahlström, C. Stafberg, J. E. Zhang, H. Leathart, H. Kohnke, A. H. Maitland-van der Zee, P. R. Williamson, A. K. Daly, P. Avery, F. Kamali, and M. Wadelius, for the EU-PACT Group. 2013. A randomized trial of genotype-guided dosing of warfarin. New England Journal of Medicine 369(24):2294–2303.
Plon, S. E., D. M. Eccles, D. Easton, W. D. Foulkes, M. Genuardi, M. S. Greenblatt, and S. Tavtigian. 2008. Sequence variant classification and reporting: Recommendations for improving the interpretation of cancer susceptibility genetic test results. Human Mutation 29(11):1282–1291.
Powell, C. 2016. Presentation at the Advisory Committee on Heritable Disorders in Newborns and Children. August 25. https://www.hrsa.gov/sites/default/files/hrsa/advisory-committees/heritable-disorders/meetings/20160825/powell.pdf (accessed March 9, 2018).
Regier, D. A., J. M. Friedman, N. Makela, M. Ryan, and C. A. Marra. 2009. Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: Willingness to pay from families of affected children. Clinical Genetics 75(6):514–521.
Regier, D. A., S. J. Peacock, R. Pataky, K. van der Hoek, G. Jarvik, and D. A. Veenstra. 2015. Societal preferences for the return of incidental findings from clinical genomic sequencing: A discrete choice experiment. CMAJ 187(6):E190–E197.
Rehm, H. L., J. S. Berg, L. D. Brooks, C. D. Bustamante, J. P. Evans, M. J. Landrum, D. H. Ledbetter, D. R. Maglott, C. L. Martin, R. L. Nussbaum, S. E. Plon, E. M. Ramos, S. T. Sherry, and M. S. Watson for ClinGen. 2015. ClinGen—The clinical genome resource. New England Journal of Medicine 372(23):2235–2242.
Richards, S., N. Aziz, S. Bale, D. Bick, S. Das, J. Gastier-Foster, W. W. Grody, M. Hegde, E. Lyon, E. Spector, K. Voelkerding, and H. L. Rehm, on behalf of the ACMG Laboratory Quality Assurance Committee. 2015. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine 17(5):405–424.
Roberts, M. C., M. Clyne, A. E. Kennedy, D. A. Chambers, and M. J. Khoury. 2017. The current state of funded NIH grants in implementation science in genomic medicine: A portfolio analysis. Genetics in Medicine Oct 26. doi: 10.1038/gim.2017.180. [Epub ahead of print]. https://www.nature.com/articles/gim2017180 (accessed March 9, 2018).
Ross, L. F., H. M. Saal, K. L. David, R. R. Anderson, the American Academy of Pediatrics, and the American College of Medical Genetics and Genomics. 2013. Technical report: Ethical and policy issues in genetic testing and screening of children. Genetics in Medicine 15(3):234–245.
Rothstein, M. A. 2005. Genetic exceptionalism & legislative pragmatism. Hastings Center Report 35(4):27–33. https://muse.jhu.edu (accessed January 18, 2018).
Sperber, N. R., S. M. Andrews, C. I. Voils, G. L. Green, D. Provenzale, and S. Knight. 2016. Barriers and facilitators to adoption of genomic services for colorectal care within the Veterans Health Administration. Journal of Personal Medicine 6(2):16.
Trivedi, B. P. 2017. Medicine’s future? Science 358(6362):436–440.
Verhoef, T. I., W. K. Redekop, S. Langenskiold, F. Kamali, M. Wadelius, G. Burnside, A. H. Maitland-van der Zee, D. A. Hughes, and M. Pirmohamed. 2016. Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden. Pharmacogenomics Journal 16(5):478–484.
Walsh, J., M. Arora, C. Hosenfeld, U. Ladabaum, M. Kuppermann, and S. J. Knight. 2012. Preferences for genetic testing to identify hereditary colorectal cancer: Perspectives of high-risk patients, community members, and clinicians. Journal of Cancer Education 27(1):112–119.
Wilson, J. M. G., and G. Jungner. 1968. Principles and practice of screening for disease. Geneva: World Health Organization.
This page intentionally left blank.
